Verso Capital
News,Investments,Singapore,Biotech / MedTech
Singapore BioTech TurtleTree raises $30M Series A funding led by European investor VERSO Capital
Turtle Tree has successfully raised $30 million in the first tranche of its Series A funding, one of the largest investment rounds to date in Asia's cell-based food sector. The funding sees participation from investors worldwide, including lead investor VERSO Capital. Following this round of funding, TurtleTree has now raised over US$40 million to date.
November 2, 2021